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Interleukin-1b converting enzyme (ICE)-related cysteine proteases are required for E1A-induced, p53-dependent apoptosis
in baby rat kidney (BRK) cells. Adenovirus E1B 19K protein, which is a potent inhibitor of apoptosis, inhibits activation of these
proteases in BRK cells. E1A expression induces apoptosis during infection of human cells by mutant adenoviruses which
contain nonfunctional E1B 19K. The question arises as to whether ICE-related proteases are involved in E1A-induced
apoptosis during mutant adenovirus infection of human cells. To test the involvement of the cysteine proteases in
E1A-induced apoptosis during productive adenovirus infection of HeLa cells, we examined whether Z-VAD-FMK, an inhibitor
of ICE-related proteases, can inhibit apoptosis induced by mutant adenovirus which lacks functional E1B 19K. Z-VAD-FMK
inhibited E1A-induced apoptosis in adenovirus-infected Hela cells, suggesting that the ICE family proteases are involved in
this apoptosis pathway. Z-VAD-FMK also inhibited cleavage of substrates such as cysteine protease CPP32 and nuclear
lamins, whereas cleavage of poly(ADP-ribose) polymerase was partially inhibited during infection with an E1B 19K mutant.
Inhibition of apoptosis by Z-VAD-FMK significantly enhanced production of infectious adenovirus and attenuated virus
release. Thus apoptosis may be a method for the host cell to limit virus production and release at the end of the infection
cycle. © 1998 Academic Press
INTRODUCTION
During adenovirus infection, E1A expression induces
apoptosis, while E1B 19K expression inhibits apoptosis.
Therefore, infection of HeLa cells by wild-type adenovi-
rus, which expresses both E1A and E1B 19K, does not
induce apoptosis (White et al., 1991, 1992). Infection of
HeLa cells with mutant adenovirus lacking functional
E1B 19K produces massive apoptosis, and this cell death
is dependent on E1A expression (Waga et al., 1994;
White et al., 1984, 1991; White and Stillman, 1987). Cleav-
age of PARP, a known substrate for interleukin-1b con-
verting enzyme (ICE)-like cysteine proteases, has been
observed previously in E1B 19K mutant adenovirus-in-
duced cell death in KB cells (Boulakia et al., 1996) and in
Sindbis virus-induced apoptosis of neuroblastoma cells
(Ubol et al., 1996), implicating the involvement of cysteine
proteases in viral infection-induced apoptosis. Further-
more, inhibition of cysteine protease activity has been
shown to enhance HIV replication by inhibiting apoptosis
(Chinnaiyan et al., 1997). Thus cysteine protease activity
appears to be an important factor in the regulation of
apoptosis and the progression of the virus life cycle.
The study of the genetic control of apoptosis in the
nematode Caenorhabditis elegans (C. elegans) first
suggested the involvement of cysteine proteases in
apoptosis. Specifically, the C. elegans death protein
Ced-3, which is one of the required factors for execu-
tion of the apoptosis program in nematodes (Ellis and
Horvitz, 1986; Hengartner and Horvitz, 1994), is a cys-
teine protease (Xue et al., 1996) homologous to the
mammalian ICE family of cysteine proteases. This
suggests a role for these ICE-related proteases in
mammalian apoptosis (Yuan et al., 1993). Numer-
ous mammalian proteases related to ICE have been
identified. These include CPP32/Yama/apopain (Fer-
nandes-Alnemri et al., 1994; Nicholson et al., 1995;
Tewari et al., 1995), Mch3/CMH1 (Fernandes-Alnemri
et al., 1995b; Lippke et al., 1995), Mch2 (Fernandes-
Alnemri et al., 1995a), Mch4 (Fernandes-Alnemri et al.,
1996), Mch5 (Fernandes-Alnemri et al., 1996), ICE rel
II/Tx/ICH-2 (Faucheu et al., 1995; Kamens et al., 1995;
Munday et al., 1995), ICE rel III (Munday et al., 1995),
and Ich-1 (Wang et al., 1994). These proteases are now
collectively referred to as ‘‘caspases’’ (Alnemri et al.,
1996). An insect caspase, Spodoptera frugiperda
caspase-1, has also been found recently, which is
inhibitable by the anti-apoptotic baculovirus p35 pro-
tein (Ahmad et al., 1997). Drosophila melanogaster
also encodes caspases that are required for apopto-
sis, such as drICE and DCP-1 (Fraser and Evan, 1997;
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Harvey et al., 1997; Song et al., 1997). Thus caspases
appear to be important for apoptosis across different
phyla.
Presumably, activation of caspases during apoptosis
results in cleavage of a number of cellular substrates
which lead to the apoptotic phenotype. Substrates for the
caspases include the retinoblastoma tumor suppressor
protein (pRb), interleukin-1b, nuclear lamins, and poly-
(ADP-ribosepolymerase (PARP) (Enari et al., 1996; Jan-
icke et al., 1996; Lazebnik et al., 1994; Orth et al., 1996).
Although the roles of interleukin-1b and PARP cleavage
in apoptosis are unclear, lamin cleavage has been
shown to be an important event in the apoptotic process,
since overexpressed uncleavable lamins delay DNA
degradation and cell death (Rao et al., 1997). Specific
caspases which cleave pRb have not been identified,
although pRb degradation has been observed during
apoptosis induced by TNF-a, Fas, and staurosporine,
and inhibitors of caspases have been shown to block
both pRb cleavage and apoptosis (Janicke et al., 1996;
Tan et al., 1997). Since pRb has known anti-apoptosis
activity (Berry et al., 1996; Haas-Kogan et al., 1995;
Howes et al., 1994; McConkey et al., 1996), degradation
of pRb may also be an important event in apoptosis.
Overexpression of caspases has been shown to in-
duce apoptosis and cellular as well as viral inhibitors of
apoptosis inhibit the activation or activity of caspases
(Boulakia et al., 1996; Bump et al., 1995; Komiyama et al.,
1994; Kumar, 1995; Martin and Green, 1995; Nicholson,
1996; Sabbatini et al., 1997; Tewari and Dixit, 1995; Xue
and Horvitz, 1995). Cleavage of substrates by specific
caspases is blocked by viral inhibitors such as CrmA
from cowpox virus and p35 from baculovirus (Bump et al.,
1995; Komiyama et al., 1994; Tewari and Dixit, 1995; Xue
and Horvitz, 1995). The Bcl-2 cellular oncoprotein and the
adenovirus E1B 19K both inhibit activation of caspases
(Boulakia et al., 1996; Sabbatini et al., 1997).
Synthetic peptide inhibitors have been developed and
are designed based on conserved amino acid se-
quences in the substrate cleavage sites of the different
proteases. Substrate cleavage sites for the caspases
generally contain a tetrapeptide motif. ICE cleaves most
effectively at the tetrapeptide sequence Tyr-Val-Ala-Asp
(YVAD), whereas CPP32 most effectively cleaves at Asp-
Glu-Val-Asp (DEVD) (Zhu et al., 1995). Synthetic peptide
aldehyde inhibitors containing these sequences have
been useful in identifying the role of specific caspases in
apoptosis. An aspartate residue in the tetrapeptide se-
quence at the P1 position and at least four amino acids
on the amino-terminal side of the cleavage site are
required for cleavage to occur. Removal of the amino
acid in the P4 position in the peptide aldehyde inhib-
itor benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone
(Z-VAD-FMK) renders it a general inhibitor of caspases
(Zhu et al., 1995).
It has been shown earlier that Z-VAD-FMK inhibits
E1A-induced apoptosis in BRK cells, suggesting that
caspases are involved in this apoptosis pathway (Sab-
batini et al., 1997). Nuclear lamin cleavage, which is
indicative of Mch2 activity, and active CPP32 subunits
have been observed during E1A-induced apoptosis in
baby rat kidney (BRK) cells (Rao et al., 1996; Sabbatini et
al., 1997). Thus Mch2 and CPP32 are involved in this
apoptosis pathway. Furthermore, E1B 19K expression
blocks E1A-induced apoptosis and also inhibits activa-
tion of these caspases in BRK cells (Rao et al., 1996;
Sabbatini et al., 1997).
E1B 19K is an anti-apoptosis member of the Bcl-2
family of apoptosis regulators, which function upstream
of caspase activation (Boulakia et al., 1996; Rao et al.,
1996). The mechanism of inhibition of caspases by anti-
apoptotic Bcl-2 family members is unclear. It is possible
that anti-apoptotic Bcl-2 family members express a sur-
vival signal that inhibits caspase activation or that they
inhibit a death signal mediated by pro-apoptotic Bcl-2
family members Bax, Nbk/Bik, and Bak to activate
caspases (reviewed in Rao and White, 1997).
Since caspases play a role in E1A-induced apoptosis
in BRK cells, the question arises as to whether E1A-
induced apoptosis in mutant adenovirus-infected HeLa
cells also involves caspases. To test the involvement of
the caspases in E1A-induced apoptosis during adenovi-
rus infection of HeLa cells, we evaluated whether the
Z-VAD-FMK peptide inhibitor could inhibit apoptosis dur-
ing E1B 19K mutant adenovirus infection of HeLa cells.
Z-VAD-FMK inhibited E1A-induced apoptosis as well as
cleavage of specific substrates such as CPP32 and nu-
clear lamins. PARP cleavage was reduced but not inhib-
ited upon Z-VAD-FMK treatment. The consequence of
inhibition of apoptosis by Z-VAD-FMK was to increase
infectious virus production and to attenuate virus release
from the infected cells.
In both wild-type and 19K mutant adenovirus infection,
the efficiency of virus release from the host HeLa cells
was similarly decreased by treatment with Z-VAD-FMK.
Thus inhibition of apoptosis by Z-VAD-FMK diminished
virus release regardless of whether E1B 19K is present.
This suggested that inhibition of apoptosis is required
but E1B 19K activity is dispensable for blocking virus
release.
RESULTS
Inhibition of caspase activity inhibits E1A-Induced
apoptosis during adenovirus infection of HeLa cells
Of the caspases, ICE, CPP32, and Mch2 activity has
been detected in cells undergoing apoptosis (reviewed in
Fraser and Evan, 1996). Stable expression of CrmA did not
inhibit E1A-induced apoptosis in infected HeLa cells (data
not shown), suggesting that ICE itself may be dispensable
for this form of apoptosis or that E1A triggers redundant
pathways in HeLa cells. To determine whether ICE-like
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caspases in general are involved in E1A-induced apoptosis
during adenovirus infection, we tested whether inhibition of
caspase activity by Z-VAD-FMK could inhibit induction of
apoptosis during infection of HeLa cells by mutant adeno-
virus lacking functional E1B 19K.
HeLa cells were mock infected, infected with the wild-
type Ad5dl309 virus, or infected with the Ad5dl337 virus,
which contains a deletion in the E1B 19K coding se-
quence and induces apoptosis (Pilder et al., 1984; White
et al., 1984; White and Stillman, 1987). Infected HeLa
cells were then treated in parallel with either the Z-FA-
FMK control peptide or the Z-VAD-FMK peptide inhibitor.
Apoptosis induction was monitored by observing the
appearance of extreme changes in the cell morphology
(cyt phenotype) and DNA degradation (deg phenotype).
Mock-infected cells treated with either control peptide
or Z-VAD-FMK did not exhibit any cyt phenotype (Fig. 1).
HeLa cells infected by Ad5dl309 and treated with either
Z-FA-FMK or Z-VAD-FMK peptide also did not exhibit the
cyt phenotype (Fig. 1). Thus peptide treatment did not
produce nonspecific morphological effects on mock- or
wild-type virus-infected HeLa cells. Cells that were in-
fected by Ad5dl337 and were treated with the control
peptide exhibited the cyt phenotype, apparent from the
extensive rounding and detaching of cells from the dish
(Fig. 1). This was expected since the control peptide
would not protect the cells from induction of apoptosis by
Ad5dl337 virus infection. In contrast, treatment of
Ad5dl337-infected cells with the Z-VAD-FMK inhibitor
blocked induction of the pronounced morphological
changes characterized by the cyt phenotype (Fig. 1).
Thus inhibition of caspases inhibited morphological in-
dications of apoptosis during mutant adenovirus infec-
tion, suggesting that caspases play a role in those
events caused by E1A-induced apoptosis during adeno-
virus infection of human cells.
Analysis of the deg phenotype showed similar results.
Mock-infected cells and cells infected by Ad5dl309 did not
display DNA fragmentation, and treatment with either pep-
tide had no effect (Fig. 2, left panel). The deg phenotype
was observed in cells infected by Ad5dl337 treated with the
control peptide, as indicated by the appearance of DNA
fragmentation, but was not observed in cells treated with
the Z-VAD-FMK inhibitor (Fig. 2, left panel). Restriction anal-
ysis of viral DNA from infected cells indicated efficient viral
replication had taken place to a similar extent in all the
infections (Fig. 2, right panel), indicating that Z-VAD-FMK did
not block apoptosis by inhibiting virus replication. Thus, by
inhibiting ICE-like caspases, two distinct apoptosis pheno-
types (cyt and deg) in mutant adenovirus-infected HeLa
cells were inhibited.
The Z-VAD-FMK inhibitor blocks the proteolysis of
specific substrates during apoptosis in adenovirus-
infected HeLa cells
Inhibition of apoptosis by Z-VAD-FMK during E1B 19K
mutant adenovirus infection implies that the protection
FIG. 1. Z-VAD-FMK treatment inhibits appearance of the cyt phenotype indicative of apoptosis in adenovirus-infected HeLa cells. HeLa cells were
mock infected or infected with the Ad5dl309 or Ad5dl337 viruses at a m.o.i. of 100 PFU/cell. 25 mm of Z-VAD-FMK or Z-FA-FMK was added to each
infection at 6 h postinfection. At 48 h postinfection the appearance of the cyt phenotype was monitored. The peptide treatments are indicated on the
left. Virus infections are indicated above each panel. Original magnification, 325.
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from cell death is due to blockage of caspase activity in
the infected cells. Proteolytic activation of CPP32 and
cleavage of nuclear lamins and PARP have been shown
to occur during E1A-induced, p53-mediated apoptosis in
BRK cells (Rao et al., 1996; Sabbatini et al., 1997), and
Z-VAD-FMK inhibits these cleavage events (Sabbatini et
al., 1997). To determine whether these proteolytic events
also occur in E1B 19K mutant adenovirus-infected HeLa
cells undergoing apoptosis, and whether Z-VAD-FMK
treatment can inhibit cleavage of these substrates,
CPP32, nuclear lamins, and PARP were monitored con-
currently with manifestation or inhibition of the cyt and
deg phenotypes.
Activation of CPP32 entails processing of the inactive
zymogen into p17 and p11 active subunits (Nicholson et
al., 1995). Detection of either subunit on a Western blot
indicates that CPP32 is processed. Extracts from apop-
tosing BRK cells and live BRK cells were used as positive
and negative controls, respectively, for the presence of
the p17 active subunit of CPP32 (Fig. 3). The p17 subunit
was absent in cell extracts from mock-infected and
Ad5dl309-infected cells treated with either Z-FA-FMK or
Z-VAD-FMK (Fig. 3). Thus CPP32 was inactive in mock-
infected and adenovirus-infected HeLa cells inhibited
from undergoing apoptosis by E1B 19K expression. Sim-
ilar findings were reported indicating that E1B 19K acts
upstream to inhibit caspase activation in BRK cells (Sab-
batini et al., 1997). In cells infected by Ad5dl337 in the
presence of control peptide that were undergoing apop-
tosis, p17 was present in abundance (Fig. 3), whereas
treatment of Ad5dl337-infected cells with the Z-VAD-FMK
inhibitor blocked the appearance of p17 (Fig. 3). Thus
CPP32 was activated in cells undergoing apoptosis and
inhibited from activation when cells were rescued from
apoptosis by Z-VAD-FMK.
Cleavage of nuclear lamins A/C into 47K and 37K
proteolysis products has been observed in apoptosing
cells (Ankarcrona et al., 1996; Oberhammer et al., 1994;
Orth et al., 1996; Rao et al., 1996; Takahashi et al., 1996).
In mock-infected and Ad5dl309-infected HeLa cells
treated with either the control or the Z-VAD-FMK peptide,
lamin cleavage was undetectable by Western blot anal-
ysis (Fig. 3), as was expected since these cells were
viable. A band migrating close to 47K is observed in the
lane representing mock infection treated with Z-VAD-
FMK (Fig. 3). However, this band migrates slightly below
47K, suggesting that it is only a background band. Also,
the 37K lamin cleavage product is absent in the lane,
suggesting that the enzymatic activity which produces
this product is absent. The cleavage products of lamins
FIG. 3. Inhibition of cleavage of CPP32, nuclear lamins, and PARP
during apoptosis in mutant adenovirus-infected HeLa cells by Z-VAD-
FMK treatment. Whole cell lysates were made from the mock- or
virus-infected HeLa cells treated with either Z-VAD-FMK or Z-FA-FMK
(Fig. 1), and cleavage products of CPP32, laminA/C, and PARP were
monitored by Western blot analysis. The CPP32-p17 polyclonal anti-
body was used to detect the p17 active subunit of CPP32. The mono-
clonal antibodies C2-10 and IE4 were used to detect PARP and lamin
A/C, respectively. p53AN1, a BRK cell line transformed by E1A and a
temperature-sensitive p53(val135) mutant. 32°C, protein extract from
apoptosing p53AN1 cells serving as positive control for CPP32 activa-
tion. 38°C, protein extract from healthy p53AN1 cells serving as neg-
ative control for CPP32 activation. Viral infections are indicated at the
top of the panel; (1) presence of the indicated peptide and (2) absence
of the indicated peptide. The full-length CPP32 and the active p17
subunit are indicated on the right. The full-length and cleavage prod-
ucts of both PARP and lamin A/C are also indicated on the right.
FIG. 2. Z-VAD-FMK treatment inhibits DNA degradation (deg pheno-
type) during apoptosis in adenovirus-infected HeLa cells. HeLa cells
were mock infected or infected and then treated with peptides as
described in Fig. 1. Concurrent to the observation of the cyt phenotype
in Fig. 1, Hirt DNA was isolated from each infection and peptide
treatment. The deg phenotype was monitored by agarose gel electro-
phoresis. Treatment with control peptide or Z-VAD-FMK is indicated on
the left. Viral infections are indicated above each lane. Panels: left,
undigested DNA; right, HindIII-digested DNA.
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A/C were detected in Ad5dl337-infected cells treated
with control peptide and undergoing apoptosis, but not in
Ad5dl337-infected cells rescued from apoptosis by the
Z-VAD-FMK peptide inhibitor (Fig. 3).
Cleavage of PARP into an 85K product has also been
observed during apoptosis, as a function of CPP32,
Mch2, Mch3, or Ich-1 activity (Fernandes-Alnemri et al.,
1994, 1995a,b; Nicholson et al., 1995; Tewari et al., 1995;
Wang et al., 1994). In mock-infected cells, the 85K PARP
cleavage product was observed at very low background
levels (Fig. 3). Since a small amount of background PARP
cleavage was observed in both Z-FA-FMK- and Z-VAD-
FMK-treated cells, it appeared to be a nonspecific event.
What caused the background PARP cleavage is unclear.
It could be that there is basal PARP cleavage activity
present in the live cell or that there are background
levels of cell death. If the PARP cleavage is due to
background cell death, it is unlikely to be caused by
toxicity of the Z-VAD-FMK inhibitor alone since the level
of PARP cleavage in both the control peptide- and the
Z-VAD-FMK inhibitor-treated samples were equivalent. In
Ad5dl309-infected HeLa cells, PARP cleavage was unde-
tectable (Fig. 3), as expected since E1B 19K is present in
a wild-type adenovirus infection, and is reported to func-
tion upstream of protease activation (Boulakia et al.,
1996; Rao et al., 1996; Sabbatini et al., 1997). In cells
infected with Ad5dl337 that were undergoing apoptosis
in the presence of control peptide, the 85K PARP cleav-
age product was detected in abundance, as expected
since CPP32 was activated (Fig. 3), and lamin cleavage
indicative of Mch2 activity was observed (Fig. 3). How-
ever, the 85K PARP cleavage product was also present in
relative abundance in Ad5dl337-infected cells treated
with Z-VAD-FMK, even though CPP32 activation and
lamin cleavage were inhibited and cells were rescued
from apoptosis (Fig. 3). It is conceivable that PARP cleav-
ing proteases other than CPP32 were present. Alterna-
tively, PARP cleavage may not be involved in apoptosis,
since basal levels of the PARP cleavage product were
detected in mock-infected cells, which were not under-
going apoptosis (Fig. 3).
Inhibition of apoptosis by Z-VAD-FMK increases virus
yield
It has been suggested that apoptosis is a mechanism
by which the host cell prematurely terminates viral infec-
tion. If this is true, than inhibition of apoptosis would
allow infection to go to completion, thus increasing the
total virus production. To determine whether inhibition of
apoptosis by Z-VAD-FMK could increase virus produc-
tion, the infectious virus yield from E1B 19K mutant ad-
enovirus-infected and apoptosing cells were compared
to that from infected cells rescued from apoptosis by
Z-VAD-FMK. The infectious virus yield from wild-type ad-
enovirus infection served as a control.
The virus yield from Ad5dl309-infected cells treated
with Z-VAD-FMK was 1.0 3 108 PFU/ml, which was 11
times greater than that from the same infection treated
with control peptide (8.8 3 106 PFU/ml) (Fig. 4). Thus
Z-VAD-FMK augmented virus replication independent of
inhibition of apoptosis by E1B 19K.
The Ad5dl337-infected cells treated with Z-VAD-FMK
produced a virus yield of 8.4 3 108 PFU/ml, which was
about 300-fold greater than the virus yield from control
peptide treatment (3.0 3 106 PFU/ml) (Fig. 4). Thus inhi-
bition of apoptosis contributed even more greatly to an
increase in virus yield in the absence of E1B 19K expres-
sion. It was unexpected that virus production by
Ad5dl337 in the presence of ZVAD-FMK would be dra-
matically greater than with the wild-type adenovirus (Fig.
4). This suggested that the E1B 19K protein may sup-
press virus replication independent of its role as an
apoptosis inhibitor.
A second set of replication-defective adenoviruses
(12S and 12S.337) expressing the 12S E1A product were
also evaluated in the same assay. Both 12S and 12S.337
viruses express only the 12S gene product of E1A, which
lacks a region that transactivates expression of down-
stream viral genes and renders the virus partially defec-
tive for replication (Berk, 1986; Lillie et al., 1987; Moran et
al., 1986; Moran and Mathews, 1987), but 12S.337 has a
FIG. 4. Inhibition of apoptosis by Z-VAD-FMK causes an increase in
virus production in HeLa cells. HeLa cells were infected with Ad5dl309,
Ad5dl337, 12S, or 12S.337 viruses and then treated with either Z-FA-
FMK or Z-VAD-FMK. When infection is complete as indicated by cells
rounding up and floating off the surface of the dish, cells and culture
medium were harvested and infectious virus yield was determined by
plaque formation on 293 cells. Infection was complete after 48 h for
Z-FA-FMK-treated Ad5dl309 and Ad5dl337 infections and after 72 h for
Z-VAD-FMK-treated Ad5dl309 and Ad5dl337 infections and all the 12S
and 12S.337 infections. The Y axis represents the virus yield in
PFU(3103)/ml. The X axis represents the different viral infections and
peptide treatments. The gray columns represent infectious virus yields
from infections treated with the Z-FA-FMK control peptide. Hatched
columns represent infectious virus yield from infections treated with
Z-VAD-FMK. Viruses used for each infection are indicated at the bottom
of the graph.
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deletion of the E1B 19K gene (White et al., 1988). As a
result, 12S.337 potently induces apoptosis in infected
HeLa cells (White et al., 1988; White and Stillman, 1987).
The cyt and deg phenotypes are more pronounced in
12S.337-infected cells than in Ad5dl337-infected cells
(White et al., 1988; White and Stillman, 1987).
Z-VAD-FMK treatment of 12S-infected cells resulted in
a virus yield of 1.76 3 107 PFU/ml, which was 10 times
greater than that of the control peptide treatment (1.8 3
106 PFU/ml) (Fig. 4). Z-VAD-FMK treatment of 12S.337-
infected cells produced a virus yield of 6.6 3 108 PFU/ml,
which was about 200 times greater than that from the
control peptide treatment (3.4 3 106 PFU/ml) (Fig. 4). As
in the case with Ad5dl337, Z-VAD-FMK treatment greatly
enhanced 12S.337 virus replication over and above that
of the 12S virus. From both sets of infections, inhibition of
apoptosis by Z-VAD-FMK significantly increased infec-
tious virus yields, suggesting that inhibition of caspases
and apoptosis contributes to completion of the adenovi-
rus infection cycle and maximization of viral progeny
production in the host HeLa cells.
Inhibition of apoptosis by Z-VAD-FMK attenuates
release of viral particles into the environment
Another event in apoptosis in infected cells is prema-
ture cell lysis and release of virus into the extracellular
environment. To test whether inhibition of apoptosis by
Z-VAD-FMK has any effect on virus release from infected
HeLa cells, the percentages of virus release from the
Ad5dl309, 12S, Ad5dl337, and 12S.337 infections treated
with Z-VAD-FMK were compared to those from the same
infections treated with control peptide. Virus release
from cells infected by Ad5dl309 and treated with Z-VAD-
FMK was fourfold less than that from Ad5dl309-infected
cells treated with control peptide (Fig. 5). With Z-VAD-
FMK treatment, a fourfold reduction in virus release was
observed in the Ad5dl337 infection (Fig. 5). The reduction
in the percentage of virus release from Ad5dl309 infec-
tion was similar to that from Ad5dl337 infection. Thus the
effect of Z-VAD-FMK on virus release was independent of
E1B 19K, since functional E1B 19K is not expressed in
Ad5dl337 infection. Compared to the control peptide
treatment, Z-VAD-FMK treatment of 12S-infected cells
resulted in a twofold reduction in virus release (Fig. 5).
Compared to control peptide treatment, Z-VAD-FMK
treatment of 12S.337-infected cells resulted in sixfold
less virus release (Fig. 5). Thus, the reduction in the
percentage of virus release by Z-VAD-FMK treatment was
threefold greater in the 12S.337 infection than in the 12S
infection. Surprisingly, there was a reduction in virus
release in all the infections by Z-VAD-FMK treatment.
DISCUSSION
Inhibition of caspase activity in BRK cells blocks E1A-
induced, p53-mediated apoptosis (Rao et al., 1996; Sab-
batini et al., 1997). We report here that inhibition of
caspase activity also blocks E1A-induced apoptosis dur-
ing adenovirus infection of HeLa cells. Specifically, our
results showed that CPP32 and caspases which cleave
lamin and/or PARP and possibly Mch2, Mch3, and Ich-1
(Fernandes-Alnemri et al., 1994, 1995a,b; Nicholson et al.,
1995; Orth et al., 1996; Tewari et al., 1995; Wang et al.,
1994) are likely involved in E1A-induced apoptosis. Our
results also suggest that Z-VAD-FMK inhibits the apopto-
sis pathway at, or upstream of, CPP32 activation, since
CPP32 cleavage was detected in apoptosing cells and
absent in protected cells. If Z-VAD-FMK inhibits the path-
way upstream of CPP32, this would suggest that
caspase activation in infected HeLa cells occurs in a
cascade fashion and that CPP32 activation depends on
the activity of an upstream caspase. Z-VAD-FMK also
blocks the caspase pathway upstream of the lamin
cleavage activity, since lamin cleavage is detected in
dying cells but not in protected cells.
E1A expression during adenovirus infection of HeLa
cells has been shown to induce both p53-dependent and
-independent forms of apoptosis (Chiou and White, 1997;
Teodoro et al., 1995). Also, the viruses used in this study
contain intact E1B 55K. The observation that E1B 55K can
inhibit p53-induced cell death (Marcellus et al., 1996), but
is insufficient to inhibit E1A-induced apoptosis in HeLa
cells, suggests that a p53-independent apoptosis path-
way is active during infection. Whether E1B 55K is suffi-
cient to inhibit p53-induced apoptosis in our experiments
FIG. 5. Inhibition of apoptosis attenuates release of viral particles
from infected HeLa cells. HeLa cells were infected with Ad5dl309,
Ad5dl337, 12S, or 12S.337 viruses and treated with either Z-FA-FMK or
Z-VAD-FMK. When infection is complete (see Fig. 4), cells were sepa-
rated from the culture supernatant, the infectious virus yield in the
supernatant and cell pellet were determined, and the percentage of
virus release was calculated. The percentage of virus release was
calculated as the (virus yield in the supernatant/total virus yield) 3100.
The Y axis represents the percentage of virus yield. The X axis repre-
sents the different viral infections and peptide treatments. Open col-
umns represent the percentage of virus release from infected cells
treated with control peptide. Hatched columns represent the percent-
age of virus yield from infected cells treated with Z-VAD-FMK.
113INHIBITION OF ICE-LIKE PROTEASES INHIBITS APOPTOSIS
is unclear since both p53-dependent and -independent
apoptosis are activated. Complete blockage of apoptosis
in Ad5dl337-infected HeLa cells by Z-VAD-FMK sug-
gested that caspases are essential for both p53-depen-
dent and -independent forms of apoptosis in infected
HeLa cells. There is evidence, however, that inhibition of
caspase activity with the Z-VAD-FMK inhibitor does not
inhibit apoptosis induced by DNA damage, which has
been shown to require p53, in Rat-1 fibroblasts (Kastan et
al., 1991; McCarthy et al., 1997). One explanation for this
aparent inconsistency is that different cell types have
been used to study inhibition of p53-dependent apopto-
sis by Z-VAD-FMK (McCarthy et al., 1997; Sabbatini et al.,
1997), and different caspases may be expressed in the
different cell types. There may be caspases in the p53-
dependent apoptosis pathway in Rat-1 fibroblasts which
are uninhibitable by Z-VAD-FMK. Another explanation is
that the concentrations of Z-VAD-FMK used may be in-
sufficient to completely inhibit apoptosis. A third expla-
nation is that there are caspase-independent apoptosis
pathways in Rat-1 fibroblasts.
Apoptosis induction is thought to be a host cell de-
fense against viral infection. Inhibition of apoptosis has
been reported to enhance production of human immu-
nodeficiency virus (Antoni et al., 1995; Chinnaiyan et al.,
1997; Sandstrom et al., 1996), simian immunodeficiency
virus (Chang et al., 1993), and the baculovirus Autogra-
pha californica nuclear polyhedrosis virus (Clem and
Miller, 1993) during infection of their respective host
cells. Furthermore, adenovirus, Epstein–Barr virus, hu-
man herpes virus 8, herpes simplex virus, African swine
fever virus, and baculovirus all encode specific genes
which inhibit apoptosis (Afonso et al., 1996; Brun et al.,
1996; Cheng et al., 1997; Leopardi and Roizman, 1996;
White et al., 1992), reviewed in (Gooding, 1992; White,
1993; White and Gooding, 1994).
Loss of E1B 19K, which allows apoptosis to occur
during adenovirus infection, is expected to result in less
virus production. However, this is true for some, but not
all, cell types (Pilder et al., 1984). In HeLa and WI38 cells,
loss of E1B 19K function in mutant adenoviruses pro-
motes viral production rather than attenuates it (White et
al., 1988). In these cell types, E1B 19K suppresses E1A
expression and dampens E1A-dependent viral gene ex-
pression (White et al., 1988). E1A expression stimulates
cell cycle progression, which is believed to provide the
machinery for efficient virus replication (reviewed in Mo-
ran, 1993). Thus downregulation of E1A expression by
E1B 19K may suppress cell cycle progression and virus
replication (White et al., 1988). The net result of E1B 19K
expression during infection is that virus production is
enhanced by inhibition of apoptosis but slowed by inhi-
bition of cell cycle progression due to downregulation of
E1A expression.
Inhibition of apoptosis by Z-VAD-FMK during E1B 19K
mutant adenovirus infection of HeLa cells caused an
increase in virus production. This observation is ex-
pected since Z-VAD-FMK inhibited apoptosis in the ab-
sence of any negative effects on virus replication due to
the absence of E1B 19K. Z-VAD-FMK also slightly in-
creased production of the wild-type Ad5dl309 and 12S
viruses, which did not detectably induce premature cell
death. This may be possible if E1B 19K expression alone
does not completely inhibit apoptosis, but Z-VAD-FMK
treatment gives additive protection from apoptosis. An-
other possibility is that E1B 19K inhibits apoptosis early
during infection, but loses its protective function late
during infection, thus allowing apoptosis to be reacti-
vated. In this case, Z-VAD-FMK may inhibit the apoptosis
late during infection, thus extending the adenovirus life-
cycle to allow for more virus production. Alternatively,
inhibition of caspases may enhance virus production
independently of apoptosis inhibition.
Inhibition of apoptosis by Z-VAD-FMK also caused a
reduction in the release of all the virus we tested from
the host cell. This suggests that not only did premature
virus released from the Ad5dl337 and 12S.337 infections
occur by apoptosis, but also that the final release of viral
particles from the Ad5dl309 and 12S infections may also
have occurred by apoptosis. Alternatively, it is possible
that caspases that are unrelated to apoptosis but inhib-
itable by Z-VAD-FMK are involved in the final virus re-
lease mechanism. A third possibility exists that the re-
duction in virus release is the result of a combination of
increased virus production due to Z-VAD-FMK treatment
and an unaltered rate of virus release by the host cell. In
this case, neither apoptosis nor caspases need be re-
quired for virus release.
The possibility that apoptosis is responsible for re-
lease of virus particles at the end of a wild-type virus
infection supports the idea that E1B 19K is not functional
at late stages during infection. The primary function of
E1B 19K may be inhibition of E1A-induced apoptosis
early in the adenovirus infection by downregulation of
E1A expression (White et al., 1988) and through interac-
tion with the proapoptotic Bcl-2 family members Bax and
Nbk/Bik (Boyd et al., 1994, 1995; Han et al., 1996a,b).
Then E1B 19K function may be actively shut down late
during infection to allow cytolysis of the host cell and
release of viral progeny.
An adenovirus E3-11.6K protein, also termed the ade-
novirus death protein (ADP), has been proposed to be
responsible for cytolysis of adenovirus infected cells at
late stages of infection (Tollefson et al., 1996). The pos-
sibility arises that ADP may inhibit E1B 19K activity, and
possibly the activity of other Bcl-2 family members, late
during infection and thereby induce apoptosis to pro-
mote virus release. Z-VAD-FMK may inhibit the ‘‘late ap-
optosis’’ induced by suppression of E1B 19K function,
which can account for the reduced virus release. How-
ever, ADP has not been shown to induce morphological
changes reminiscent of apoptosis (Tollefson et al., 1996).
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Thus, the possibility arises that the final cytolysis of
adenovirus-infected cells is a pathway distinct from ap-
optosis, but caspases are involved in both events. In
conclusion, Z-VAD-FMK-inhibitable proteases may play a
role in modulating the cellular response to adenovirus
infection by both inducing apoptosis and enabling virus
release.
MATERIALS AND METHODS
Cells, viruses, and viral infections
HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) fortified with 10% fetal bovine
serum (FBS). The wild-type Ad5dl309 virus and the mu-
tant Ad5dl337 virus, which lacks functional E1B 19K due
to a deletion in the E1B 19K open reading frame, were
used in the experiments and were described earlier
(Jones and Shenk, 1979; Pilder et al., 1984). The 12S virus
expresses only the 12S E1A gene product and the
12S.337 virus expresses 12S E1A and lacks functional
E1B 19K, and they have been described previously (Mo-
ran et al., 1986; White et al., 1988; Zerler et al., 1986).
Confluent monolayers of HeLa cells in 60-mm tissue
culture plates were infected at a multiplicity of infection
(m.o.i.) of 100 plaque-forming units (PFU)/cell with the
Ad5dl309 or the Ad5dl337 virus for the apoptosis inhibi-
tion assay (see below). For the virus production and
release assays, HeLa cells were infected with the
Ad5dl309 and Ad5dl337 viruses at an m.o.i. of 0.1 PFU/
cell, and with the replication-impaired 12S and 12S.337
viruses at an m.o.i. of 100 PFU/cell, since these replica-
tion-defective viruses have been shown to grow at high
m.o.i. (Moran et al., 1986; White and Stillman, 1987).
Protease inactivation and apoptosis inhibition assays
The peptide Z-VAD-FMK was used in the assays as a
general inhibitor of ICE-like caspases. The benzyloxycar-
bonyl-Phe-Ala-fluoromethyl ketone (Z-FA-FMK) peptide
was used as a nonspecific control peptide in the assays.
Both were purchased from Enzyme Systems Products
(Dublin, CA). Stock concentrations of 100 mM were pre-
pared by dissolving each peptide in dimethyl sulfoxide
(DMSO).
At 6 h postinfection, Z-VAD-FMK or Z-FA-FMK was
added to the cell culture at a 25 mM concentration. An
additional 25 mm of peptide was added to the cell cul-
tures 24 h later due to the short half-life of these pep-
tides. At 48 h postinfection, cells were observed for
appearance of the cyt phenotype, harvested for Hirt DNA
extraction (deg phenotype) with a modified Hirt DNA
extraction method (White et al., 1984), and harvested for
preparation of whole cell extracts for Western blot anal-
ysis.
Western blot analysis
Following infection and treatment with peptide in-
hibitors, whole cell protein extracts were prepared and
analyzed for the active p17 cleavage product of CPP32,
cleavage products of PARP, which is a known sub-
strate for CPP32, Mch2, Mch3, and Ich-1 (Fernandes-
Alnemri et al., 1994, 1995a; Nicholson et al., 1995;
Tewari et al., 1995; Wang et al., 1994), and lamins,
which are known Mch2 substrates (Orth et al., 1996).
The anti-human CPP32-p17 polyclonal antibody (gen-
erously provided by D. Nicholson, Merck Frosst, Mon-
treal, Quebec, Canada) directed against the p17 sub-
unit of human CPP32 was used to detect that polypep-
tide and its cleaved products in infected cells. The
monoclonal antibody C2-10 (Enzyme Systems Prod-
ucts) was used to detect PARP and its cleavage prod-
ucts. The 1E4 monoclonal antibody directed against
lamin A/C (generously provided by Dr. F. McKeon,
Harvard Medical School, Cambridge, MA) was used to
detect lamins A and C and their cleavage products.
Virus yield and release assays
For the virus production assay, 25 mm of Z-FA-FMK or
Z-VAD-FMK was added at 6 h postinfection and at 24-h
intervals thereafter. When infection was complete and
cells were rounded and detached from the plate, cells
and media were harvested. The control peptide-treated
Ad5dl309 and Ad5dl337 infections were harvested at
48 h postinfection, and the Z-VAD-FMK-treated samples
from the same infections were harvested at 72 h postin-
fection. All the 12S and 12S.337 infections were har-
vested at 72 h postinfection. For total virus yield, cells
plus media were frozen and thawed three times to re-
lease the virus particles. The yield of infectious virus was
determined by plaque formation on 293 cells.
For the virus release assay, cells and media were
separated after harvest by low-speed centrifugation at
1000 rpm for 3 min. The resulting cell pellet was frozen
and thawed three times and resuspended in 1 ml of
DMEM. Infectious virus yields in the media and in the
cell pellet were determined separately by plaque forma-
tion on 293 cells. The percent virus release was calcu-
lated as the ratio of infectious virus released into the
medium to the total infectious virus yield.
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